Valeant Pharmaceuticals Intl (NYSE: VRX)


Last Updated: Sep-26-2016 10:40:14

VRX News & Stock Updates

Click here to read more stories

Premium Research

Valeant Pharmaceuticals Intl (NYSE: VRX) Profile

Volume5,918,706
Open$27.45
Prior Close$26.85
Market Cap$9.08 B
PE Ratio3.41
Beta0.07
Valeant Pharmaceuticals International Inc. is a pharmaceutical company that develops manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology dermatology and branded generics. The Company produces medicines that meet the special health problems of patients. Valeant's development pipeline strategy comprises both new compounds as well as product life cycle management. Its early and late-stage drug candidates have unique formulations and mechanisms of action including retigabine for the treatment of epilepsy and pain taribavirin of the treatment of chronic hepatitis C and several dermatology candidates for the treatment of rosacea acne and dermatological fungus. Valeant Pharmaceuticals International Inc. is headquartered in Mississauga Canada.
SymbolCompanyMarket cap
SHPGShire Plc Ads$61.28 B
TKPYYTakeda Pharma$37.66 B
ALPMYAstellas Pharma Inc$33.92 B
ZTSZoetis Inc Class A Common Stoc$25.56 B
GRFSGrifols S.A.$11.2 B
JAZZJazz Pharma Plc$7.67 B
TSROTesaro Inc$5.57 B
UTHRUnited Therapeutic$5.52 B
TAROTaro Pharm Inds$5 B
NBIXNeurocrine Bioscienc$4.7 B

VRX Earnings

1st Quarter Earnings$1.4 (2016-08-09)
2nd Quarter Earnings$1.27 (2016-06-07)
3rd Quarter Earnings$2.5 (2016-03-15)
4th Quarter Earnings$2.74 (2015-10-19)
PE Ratio3.41
EPS Growth-18.72%
Recent Earnings$1.4
Annual EPS$7.88
Market Capitalization$9.08 B
Insider Shareholder %0.1637%
Annual Revenue$10.32 B
Number of Shares Outstanding341,190 Shares
Institutional Shareholder %64.77%
Annual Net Income$-0.96B
TTM Net Profit Margin$-9.58
One Year Return-86.1%
Three Year Return-37.41%
Five Year Return-28.9%
Five Year Revenue Growth784.37%
Five Year Earnings Growth541.27%
Five Year Dividend Growth-100%
Last Quarter EPS$1.4
Annual EPS$7.88
Annual Dividend$0
Annual Dividend Yield0%
Change in EPS YTD-18.719999%
PE Ratio3.41
Recent Earnings$1.4
Dividends per Share$1
Stock Split Ratio2-1
beta0.07

VRX Key Stats

Last Price$26.6
Net Change$-1.12 (-4.04%)
Bid$26.6
Ask Price$26.61
Open Price$27.45
Previous Close Price$26.85
High Price$27.58
Low Price$26.57
Number of Trades41,085
Volume5,918,706
Fifty Two Week High$217.07 (2015-09-24)
Fifty Two Week Low$18.55 (2016-06-27)
Average Daily Volume25,526,889
Share Outstanding341,190 Shares
Total Dividend Payout$0/yr
Dividend Yield0%